. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Aspirin/administration & dosageAspirin/therapeutic useCerebrovascular Disorders/prevention & controlClinical Trials as TopicDouble-Blind MethodDrug Therapy, CombinationFemaleHumansMalePlacebosPlatelet Aggregation/drug effectsSulfinpyrazone/administration & dosageSulfinpyrazone/therapeutic use
Substances: See more » PlacebosAspirinSulfinpyrazone
Year: 1980 PMID: 6989457 PMCID: PMC1801847
Source DB: PubMed Journal: Can Med Assoc J ISSN: 0008-4409 Impact factor: 8.262